FindTrial
Sign In

A study to find an early sign of diabetes by testing blood in healthy people, prediabetes, and diabetes patients.

Circulating miR-223-3p: A Novel Marker for Early Detection and Glycemic Regulation in Type 2 Diabetes Mellitus - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/093419
Enrollment
85
Registered
2025-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E168- Other specified disorders of pancreatic internal secretion Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: NIL: NIL

Sponsors

Shri BM Patil Medical College Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Body Mass Index (BMI) Between 18 point 5 and 30 kilograms per square meter No history of chronic illnesses such as chronic kidney disease and coronary artery disease and asthma and others (except Type 2 Diabetes Mellitus in the case group) No previous use of hypoglycemic drugs or insulin therapy (for prediabetes and Type 2 Diabetes Mellitus groups)

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Patients on long term medication affecting glucose metabolism

Design outcomes

Primary

MeasureTime frame
Expression levels of circulating miR 223 3p in healthy controls individuals with prediabetes and newly diagnosed T2DM patients and its correlation with glycemic parameters HbA1c fasting blood sugar insulin resistance.Timepoint: Assessed at baseline by fasting blood sample collection at enrolment—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactVISHWANATH MALKAPPA JALAWADI

BLDE Deemed to be university Shri BM Patil Medical College, Hospital and Research Centre

drvishwa.mj@gmail.com7856089869

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026